Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "breast conserving therapy" wg kryterium: Temat


Wyświetlanie 1-2 z 2
Tytuł:
Body image in women with breast cancer undergoing surgical treatment - a comparative analysis
Autorzy:
Brandt-Salmeri, Anna
Ilska, Michalina
Kołodziej-Zaleska, Anna
Powiązania:
https://bibliotekanauki.pl/articles/1933075.pdf
Data publikacji:
2019
Wydawca:
Politechnika Śląska. Wydawnictwo Politechniki Śląskiej
Tematy:
breast cancer
mastectomy
breast conserving therapy
BCT
breast reconstruction
body image
self-esteem
rak piersi
mastektomia
terapia oszczędzająca pierś
rekonstrukcja piersi
obraz ciała
samoocena
Opis:
Surgery is the most basic treatment in case of breast cancer: it involves a complete or partial removal of the mammary gland. The aim of the study was to assess the body image distress and self-esteem in a group of women with breast cancer undergoing various surgical procedures. The material was collected in a group of 229 women with breast cancer who were divided into subgroups based on the surgery criterion (mastectomy, breast-conserving therapy - BCT and mastectomy with breast reconstruction). The study used the Body Image Scale by Hopwood, Fletcher, Lee and Al Ghazal (2001; Polish adaptation by Brandt-Salmeri and Przybyła-Basista), Rosenberg Self-Esteem Scale - SES (Polish adaptation by Łaguna, Lachowicz-Tabaczek and Dzwonkowka, 2007) and an original survey. Analyses showed, among other things, significant differences in the assessment of discomfort associated with a change in body image depending on the type of surgery. The research also revealed that the assessment depended on differences between the women in terms of age and the time elapsed since the onset of treatment. Negative body image was adversely associated with self-esteem in all studied groups. Body image was significantly related to age and time elapsed since the treatment in the post-mastectomy group. At the same time, it was related only to age in the BCT group and with regards to the breast reconstruction group, the relationship concerned only elapsed time.
Źródło:
Zeszyty Naukowe. Organizacja i Zarządzanie / Politechnika Śląska; 2019, 141; 7-24
1641-3466
Pojawia się w:
Zeszyty Naukowe. Organizacja i Zarządzanie / Politechnika Śląska
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Changing paradigms in breast cancer treatment
Autorzy:
Ali, Shan
Buczek, Dagmara
Jassem, Jacek
Powiązania:
https://bibliotekanauki.pl/articles/1196786.pdf
Data publikacji:
2020-12-03
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
breast cancer
sentinel node biopsy
breast-conserving surgery
targeted therapy
molecular profiles
Opis:
In only the past century, the landscape of breast cancer treatment has completely changed. The Halstedian hypothesis of the “contiguous spread” of breast cancer has been replaced by a consideration of its systemic nature. Today, patients with early-stage breast cancer are managed with breast-conserving therapy, which is as effective as mastectomy. Sentinel lymph node biopsy has largely replaced axillary lymph node dissection. Post-operative radiotherapy, chemotherapy and endocrine therapy have increased survival. Pre-operative cytotoxic therapy allows for less extensive surgery and for a curative resection even in more advanced stages. Rapid progress in molecular oncology revealed a large heterogeneity of breast cancer, resulting in a more personalized approach. Targeted therapies directed against epidermal growth factor receptor type 2 (HER2) have improved survival in HER2-positive breast cancer, which was once a poor-prognosis entity. Multi-gene prognostic signatures better predict prognosis and allow many patients to avoid chemotherapy. Personalized treatment has resulted in decreased toxicity and an improved quality of life. Within the past decades, breast cancer has become a good-prognosis malignancy with a five-year survival in the range of 80-85%. Future development of personalized medicine may further refine treatment based on the tumor’s molecular features.
Źródło:
European Journal of Translational and Clinical Medicine; 2020, 3, 2; 53-63
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies